H&E staining indicated the alleviating effect of Ffar4 on CS‐induced emphysema, with reduced lung destruction and lower MLI in Ffar4‐overexpressing mice and TUG891‐treated mice compared to the CS group (Figure 5D). Here, FFAR4 is linked to pulmonary emphysema.